| INTRODUCTION
Status epilepticus (SE) is a serious disorder with considerable morbidity; reported mortality ranges from 2% to 40%. 1 The incidence of SE reported in epidemiological studies varies widely, with estimates of up to 61 episodes per 100 000 per year. 1, 2 There are many causes of SE, 3, 4 and the optimal management remains uncertain. 5, 6 Over the past 10 years, there has been an increase in interest in SE, at least in part because of the biennial London-Salzburg SE colloquia. 7 Due to its relatively low incidence, and variable etiology, it is likely that multicenter studies will need to be undertaken to investigate potential treatments for SE. The EpiNet project was commenced by the New Zealand chapter of the International League Against Epilepsy (ILAE) to undertake observational studies and pragmatic trials in epilepsy. 8, 9 The EpiNet-First trials of first antiepileptic drug therapy in people with newly diagnosed epilepsy are currently underway. 9, 10 The goal of EpiNet is to facilitate investigator-led collaborative research in epilepsy while simultaneously providing an online clinical record for each patient. 9 Details regarding seizure types and frequency, epilepsy syndrome, etiology, investigations, and drug history are recorded in a secure online patient database. Information is primarily collected via drop-down menus, with some free text options. Different fields can be made mandatory in various circumstances. EpiNet can be used to perform epidemiological studies. Little is known regarding the epidemiology of SE in New Zealand, so we set out to prospectively identify all patients who had an episode of SE in Auckland, New Zealand, during the course of a single year, to determine the incidence, causes, and outcomes of SE. We developed a structured online clinical record within EpiNet to collect all relevant information regarding SE, in addition to the information already collected about a patient's epilepsy. Although this particular study was conducted in a single city (Auckland), our aim was to expand the EpiNet platform so that it could be used for multicenter observational studies and pragmatic randomized controlled trials in SE.
A new classification of SE was proposed in 2015 by the ILAE expert panel, 11 and this classification was used in this study, with some minor modifications; specifically, we added some "unknown" options to ensure that cases were not squeezed into specific categories when there was genuine uncertainty. This paper focuses on the case identification and data collection process; we present preliminary results.
| MATERIALS AND METHODS
All patients aged >4 weeks who presented with a possible episode of SE to any of the five public hospitals and the major private hospital within Auckland city (population = 1.61 million) between April 6, 2015 and April 5, 2016 were identified. Patients who had either convulsive or nonconvulsive SE were included.
SE was diagnosed primarily on clinical criteria. An electroencephalogram was not mandatory but was routinely performed in patients with nonconvulsive SE.
For this study, SE was defined as any seizure exceeding 10 minutes in duration, or repeated seizures lasting >10 minutes without recovery between seizures (acute repetitive seizures). This was a pragmatic definition. Traditionally, an episode of seizure activity had to last 30 minutes to be defined as SE for epidemiological studies. However, there is widespread agreement that urgent treatment needs to be initiated at a much earlier stage, and many experts have suggested that for practical purposes, SE should be acknowledged if seizures last >5 or 10 minutes. 12, 13 The ILAE expert panel suggested that SE should be diagnosed if a tonic-clonic seizure lasts 5 minutes, or if a focal seizure with impairment of consciousness lasts 10 minutes, or if an absence seizure lasts 10-15 minutes.
11
For practical purposes, we chose a single time period that could be applied consistently by doctors working at multiple centers. We believe that nearly everyone who has a seizure lasting 10 minutes or longer in Auckland is brought to one of the public hospitals, so this duration was chosen to define an episode of SE of any type. A separate analysis was performed to look at patients who had an episode of SE lasting 30 minutes or longer, to allow comparison with other epidemiological studies.
Key Points
• A structured online clinical record to collect data regarding SE has been developed within the EpiNet platform • We have performed an epidemiological study of SE in Auckland, New Zealand (1.61 million), using the 2015 ILAE classification • 477 episodes of SE occurred in 367 patients in 1 year; 285 episodes (62%) lasted >30 minutes • 254 episodes (53%) occurred in children aged <15 years; 60 episodes (13%) occurred in those aged >65 years • 200 episodes (42%) occurred in people who had not previously had seizures
For this study, an episode of SE was considered to have terminated when a patient had been seizure-free for 6 hours. If an electroencephalogram showed electrographic seizures, then the status was considered to be continuing, even if there were no clinical seizures.
The duration of the status was calculated in two ways:
• Initial duration-from onset of the first qualifying seizure until this seizure stopped; and
• Final duration-from onset of the first qualifying seizure until the end of the seizure leading into a 6-hour seizure-free period.
Patients could have >1 episode of SE over the course of the year. Each episode was recorded separately.
Cases were excluded if the SE commenced outside Auckland, if it occurred in neonates, if there were repeated spasms, even if they lasted >10 minutes, or if SE followed anoxic brain injury. Children with febrile seizures lasting >10 minutes were included; results for these children will be analyzed separately, as well as being included in the overall analysis.
| Case identification
Multiple overlapping sources of information were used to identify cases. Emergency department (ED) staff, neurologists, physicians, pediatricians, and staff of intensive care units and the neurophysiology department notified the research staff of eligible cases. Daily lists of presentations to the emergency departments at the five public hospitals were filtered to identify patients with SE, seizure, epilepsy, convulsion, or collapse. ED records and discharge summaries for these patients were reviewed by research nurses. Hospital discharge summaries were reviewed monthly for all patients discharged from any of the public hospitals with an International Classification of Disease, 10th revision code of G40 (epilepsy), G41 (SE), or R56 (convulsions, not specified elsewhere). Hospital pharmacy dispensing lists of intravenous antiepileptic drugs were cross-referenced, and admissions to intensive care units and lists of patients assessed by "patient at risk" teams were reviewed monthly. At the end of the study, discharge diagnoses from the major private hospital were reviewed, and data regarding discharge diagnoses for patients living in Auckland were obtained from the Ministry of Health.
| SE form in EpiNet
A structured online clinical record was created in EpiNet to collect comprehensive information regarding an episode of SE.
14 The form contains subforms focused on SE Onset, Patient Care, History, and Outcome. (Figures S1-S5 .) An EpiNet record was commenced by research nurses for patients they considered to have met the entry criteria. The following information was recorded in the patient's EpiNet record:
• Age, sex, and ethnicity;
• The nature of the SE, using the classification proposed by the ILAE in 2015 11 ;
• The time of onset and duration of the SE;
• The etiology of SE, and whether the SE was due to an acute symptomatic cause 15 ; in patients with preexisting epilepsy, the underlying etiology and the immediate precipitating cause of the SE;
• The short-term outcome, including 30-day case fatality rate; and
• In patients with epilepsy, the previous seizure types, the epilepsy syndrome (if known), and the previous drug history.
The EpiNet records and the hospital records were subsequently reviewed by the first author (P.S.B.) and/or one of two epilepsy fellows (A.B., J.J.). The reviewer classified each case as certain (seizure recorded on electroencephalogram), SE beyond a reasonable doubt, probable SE, possible SE, SE unlikely, or not SE.
Possible cases were reanalyzed by the first author (P.S.B.) and one of the fellows (A.B.) who independently committed themselves (forced choice) to either probable SE or SE unlikely; where the reviewers disagreed, a second epileptologist (E.B.W.) reviewed the case, and her decision was final.
This study was approved by the Northern B New Zealand Ethics Committee and the research governance committees of Auckland District Health Board, Waitemata District Health Board, and Counties Manukau District Health Board. Informed consent was obtained from patients after they had recovered from their episode of SE; if patients did not or could not give informed consent retrospectively, the ethics committee gave us permission to record deidentified data in the EpiNet database.
Many cases were identified from multiple sources; Table 1 records the source from which cases were initially identified.
Three hundred fifty-three cases (74%) were recognized during the episode of SE, or immediately following presentation to the emergency department; 124 cases (26%) were identified retrospectively. In some cases, the diagnosis of SE was not made at presentation because there was insufficient information in the computerized record, and the diagnosis of SE was only confirmed when the discharge summary was reviewed; in other circumstances, the reason for presentation to the ED was not one of those included in our search strategy; finally, the research team was not always notified when episodes of SE occurred in patients who were already hospitalized. In these circumstances, the episodes of SE were identified by review of other sources (Table 1) .
Data provided by the Ministry of Health identified only two cases of SE that had been missed from other screening methods. No cases were identified from the private hospital.
Two hundred fifty-four episodes occurred in children aged <15 years (53%); 60 episodes occurred in those aged >65 years (13%).
Sixty patients (16%) had >1 episode of SE during the year.
Two hundred seventy-seven episodes occurred in people who were known to have had epilepsy before the episode of SE (59%).
| Duration of SE
The duration of the episode of SE was known in 461 episodes. Two hundred eighty-five episodes (62%) lasted >30 minutes, whereas 176 episodes (38%) lasted between 10 and 30 minutes ( Table 2) . Three hundred eighteen episodes (70%) comprised a single continuous seizure; 148 episodes (33%) comprised multiple seizures without recovery.
Seventy-five episodes (16%) were associated with recurrence of seizures within 6 hours of the initial resolution of SE; these patients did not finally cease the episode of SE,
F I G U R E 1 Flowchart showing how the final dataset was
identified. Note that the number of episodes assessed sums to 651. However, the number of patients in each arm does not sum to 508, as some patients had episodes in more than one category Sources from which cases of SE were initially identified are shown. The table shows the order in which cases were identified and the number of new cases identified at each step. Cases that had been flagged from the ED list, but not confirmed until the discharge summary was reviewed, are included in the EDpresentation category. The seven cases listed under the "Discharge diagnoses" category are those that had not been flagged when screening the ED list. Note that the number of episodes assessed sums to 651. However, the number of patients in each arm does not sum to 508, as some patients had episodes in more than one category. ED, emergency department; EEG, electroencephalographic; ICU, intensive care unit; NA, not applicable; NR, not recorded; SE, status epilepticus.
T A B L E 1 Identification of SE cases
as we defined it, until they had been seizure-free for 6 hours (Table 2 ).
| Hospital care
Fifty-six percent of episodes ceased before arrival at the ED. Three hundred thirteen episodes (67%) resulted in admission to the hospital from the ED. Fifty-six episodes (12%) developed after the patient had been admitted to the hospital for another reason.
Sixty-one episodes (13%) resulted in admission to an intensive care unit.
| DISCUSSION
This study has identified 477 cases of SE in 367 patients during a single year in Auckland, New Zealand. It is one of the first epidemiological studies to be performed using the latest ILAE SE classification.
We used multiple overlapping sources to optimize case ascertainment, but the vast majority of cases were identified by direct physician notification and screening of ED presentations. The additional methods of ascertainment (Table 1) identified only a small number of "new" cases of SE (8%), indicating that the methodology used to identify cases was robust, and confirming that cases were not likely to have been missed. No cases were identified at the private hospital; we believe this is correct, and that no cases of SE occurred in private hospitals. For future studies, we would recommend periodic screening of private hospitals. However, the structure of the health system in New Zealand is such that private hospitals provide elective surgery, and almost all care for acute serious health problems occurs in the public sector. Ambulances take patients with urgent problems to the public hospitals, and if patients do present to a private clinic with ongoing seizures, they are invariably sent to the closest public hospital.
As well as data regarding the SE itself, baseline health economic data have also been collected. Patients who give consent will be followed for 2 years, and the study will inform knowledge about SE in New Zealand regarding causes, prognostic factors, treatments and services the patients receive, costs (direct and indirect), and long-term outcomes.
This study demonstrates the value of the EpiNet database in the collection of data in SE. EpiNet can be used to collect data prospectively from multiple centers regarding a range of epilepsy-related conditions. It can be used for epidemiological studies, because many researchers from different sites can independently but simultaneously enter data in a standardized manner into the secure, Web-based database; however, population-based studies do need considerably more resources, because there is a significant amount of work required to ensure all cases are identified. The EpiNet platform is particularly suitable for multicenter cohort studies and randomized controlled trials in epilepsy-related disorders that are relatively uncommon, because it would take a long time for a few centers to obtain sufficient numbers of patients to answer questions definitively. A form to collect comprehensive data on SE has now been developed and tested. We hope that pragmatic trials can be commenced in the near future to determine, for instance, whether steroids should be used in the early management of SE.
